OSI Systems, Inc. OSIS
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
OSI Systems, Inc. is a U.S.-based technology company operating primarily in the security, healthcare, and optoelectronics industries. The company develops and manufactures specialized electronic systems and components used in security screening, patient monitoring, diagnostic imaging, and aerospace and defense applications. OSI Systems generates revenue through product sales, long-term service contracts, software integration, and maintenance support across both government and commercial markets. Its operations are organized around three principal business segments: Rapiscan Systems, Spacelabs Healthcare, and OSI Optoelectronics.
The company’s primary revenue drivers include cargo and baggage inspection systems, airport and border security technologies, patient monitoring systems, anesthesia and cardiology solutions, and custom optoelectronic components. OSI Systems serves government agencies, airports, healthcare providers, defense contractors, and industrial manufacturers globally. A key strategic advantage is its diversified portfolio across security and healthcare markets, allowing the company to balance exposure to public-sector procurement cycles with recurring healthcare and service revenues. Founded in 1987 by Deepak Chopra, OSI Systems evolved from an optoelectronics-focused business into a diversified technology platform through acquisitions, internal product development, and expansion into regulated end markets.
Business Operations
OSI Systems conducts business through three primary operating segments. Rapiscan Systems develops security inspection technologies including X-ray screening systems, computed tomography screening platforms, explosive detection systems, radiation detection equipment, and AI-enabled security software. This segment derives substantial revenue from government contracts, aviation security infrastructure, customs agencies, and critical infrastructure operators. Spacelabs Healthcare provides patient monitoring systems, anesthesia delivery systems, diagnostic cardiology products, and healthcare informatics software primarily to hospitals and healthcare systems. OSI Optoelectronics designs and manufactures optoelectronic devices including photodiodes, sensors, detectors, and electronic assemblies used in medical imaging, aerospace, telecommunications, semiconductor, and defense applications.
The company operates manufacturing, engineering, and service facilities across North America, Europe, Asia, and the Middle East. International operations contribute a significant share of total revenue, particularly through airport security infrastructure deployments and foreign government contracts. OSI Systems controls proprietary technologies related to imaging systems, radiation detection, signal processing, and healthcare monitoring platforms. The company also maintains service and maintenance agreements that create recurring revenue streams. Key subsidiaries include Rapiscan Systems, Spacelabs Healthcare, and OSI Optoelectronics. Public filings and investor materials identify strategic customer relationships with government agencies, airport authorities, healthcare institutions, and defense-related contractors, though some customer-specific arrangements remain confidential due to security and procurement restrictions.
Strategic Position & Investments
OSI Systems has positioned itself as a specialized provider of mission-critical technologies in security screening and healthcare diagnostics. Its strategic direction emphasizes expansion of recurring service revenue, deployment of AI-enhanced security screening systems, and continued penetration of international aviation and border security markets. The company has invested in advanced computed tomography screening technologies and automated threat detection systems to align with evolving aviation security regulations and modernization programs globally. In healthcare, the company has focused on expanding software-enabled monitoring and connected care capabilities within Spacelabs Healthcare.
Acquisitions have historically played a major role in OSI Systems’ growth strategy. The acquisitions of Spacelabs Medical and security-related assets helped establish the company’s diversified operating structure. The company continues to invest in research and development across imaging, sensing, and detection technologies. OSI Systems also participates in emerging applications involving AI-assisted image analysis, advanced sensing technologies, and integrated security ecosystems. Public disclosures indicate ongoing investment in cybersecurity, automation, and data-driven monitoring platforms, although some future-facing technology initiatives are described broadly in filings and investor communications. Data regarding certain non-public strategic partnerships is inconclusive based on available public sources.
Geographic Footprint
OSI Systems is headquartered in Hawthorne, California, and maintains operations across multiple global regions including North America, Europe, Asia-Pacific, the Middle East, and parts of Latin America. The company’s security business has a particularly strong international footprint due to government and aviation security contracts outside the United States. Manufacturing, engineering, sales, and support operations are distributed globally to support customer installations and regulatory requirements in local markets.
The company maintains a meaningful presence in international airport security infrastructure and border control programs, with deployments in numerous countries through Rapiscan Systems. Spacelabs Healthcare products are marketed internationally through direct sales teams and distributor networks serving hospitals and healthcare systems. OSI Optoelectronics supports global industrial and defense supply chains through component manufacturing and custom engineering relationships. International revenue exposure is material to the company’s financial performance, according to disclosures in SEC filings and annual reports.
Leadership & Governance
OSI Systems was founded by Deepak Chopra, who has served in leadership roles for decades and remains closely associated with the company’s long-term strategic direction. The company’s governance structure combines operational oversight with technology-focused leadership across its business segments. Public filings and investor communications emphasize disciplined capital allocation, innovation-driven growth, and expansion in regulated technology markets as central elements of management strategy.
Key executives include:
- Deepak Chopra – Chairman and Chief Executive Officer
- Alan Edrick – Executive Vice President and Chief Financial Officer
- Ajay Mehra – President and Chief Executive Officer of OSI Optoelectronics
- Mohan Ramanujam – President and Chief Executive Officer of Rapiscan Systems
- Joseph W. Sarrat – President of Spacelabs Healthcare
The company’s leadership philosophy, as reflected in investor presentations and regulatory filings, centers on technology innovation, operational efficiency, and long-term customer relationships in security and healthcare markets. Governance practices are overseen by the board of directors and supported through compliance, audit, and risk management structures disclosed in annual proxy statements and SEC filings.